Awards & Advancement

inVentive Health names president for Europe and executive VP for Asia

Tuesday, October 1, 2013 12:00 PM

Global CRO inVentiv Health has created two new positions to lead its business in Europe and Asia.

More... »

Olivier Brandicourt appointed chairman of Bayer HealthCare

Tuesday, October 1, 2013 11:00 AM

Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer executive council effective Nov. 1. Since March, professor Wolfgang Plischke has led Bayer HealthCare on an interim basis in addition to his existing duties as a Bayer board member.

More... »

Theorem Clinical Research names Joseph Sgherza head of infectious diseases

Tuesday, October 1, 2013 09:44 AM

Global CRO Theorem Clinical Research has named Joseph Sgherza vice president of biopharmaceutical development for its infectious disease franchise. Sgherza has 24 years in the pharmaceutical, biotech and CRO industries.

More... »

ClinTec International a finalist in SCRIP 2013 ‘Best CRO’ award

Monday, September 23, 2013 01:34 PM

Global CRO ClinTec International is a finalist for “Best CRO” at the SCRIP Awards 2013, to be held in London’s Lancaster Hotel Nov. 21.

More... »

PPD names VP for global product development

Monday, September 23, 2013 01:30 PM

CRO PPD has appointed Gregory Dennis, M.D., vice president of global product development. Dennis will be therapeutic area head, providing medical and scientific expertise for rheumatology, immunology and inflammatory diseases.

More... »

Perrigo appoints Keith Webber head of regulatory review

Monday, September 23, 2013 09:46 AM

Perrigo has appointed Keith Webber head of regulatory review, effective Oct. 21. This new role will have responsibility for advancing the approval of all of Perrigo's Consumer Healthcare (CHC) and Prescription Pharmaceutical (Rx) regulatory applications pending with the FDA, providing guidance on scientific and regulatory strategy for new CHC and Rx pipeline products under development and continuously advancing the quality of new regulatory applications. 

More... »

ClinicalRM awarded NIH contract

Monday, September 16, 2013 08:52 AM

CRO Clinical Research Management was awarded a contract by the Department of Health and Human Services, NIH, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). The intent of the award is to provide a broad spectrum of services for the design and conduct of phase I-IV clinical trials and clinical studies focused on the screening, diagnosis, treatment, prevention and control of sexually transmitted infections within the Sexually Transmitted Infections Clinical Trials Group (STI CTG) Program.

More... »

Tom Shepherd named CEO of Bioaster

Monday, September 16, 2013 08:47 AM

Dr. Tom Shepherd has been appointed chief executive officer of Bioaster, a Technology Research Institute focused on infectious diseases and microbiology

More... »

Novella Clinical announces new leadership roles

Tuesday, September 10, 2013 12:00 PM

Three senior executives of CRO Novella Clinical have assumed new leadership roles within the organization.

More... »

AMRI announces executive leadership changes

Tuesday, September 10, 2013 10:01 AM

CRO Albany Molecular Research has announced Thomas E. D'Ambra, Ph.D., will retire as president and chief executive officer, effective Dec. 31. D'Ambra will be named non-executive chairman of the board of directors on the same date.

More... »